sign in
sign in
register
Rules
Sign in with Facebook
Sign in with Linkedin
Remember me
INVESTORS
My Home
Small Cap Marketplace
Broadcast Center
Request New Hub
Quick Tips
Ratings & Ranks
PUBLIC COMPANIES
Investor Relations
Success Stories
Clients
Testimonials
Contact
Conferences
About us
A revenue-generating, small-cap Canadian pharmaceutical company
Revenue Projected at $150,000,000 by 2025
top rated messages
latest 24 hours
this week
this month
all time
VIDEO – Valeo Pharma (VPH: CSE) Projecting Record Q2 Revenue As New Drugs Hit The Market. Next Drug Hits Market June 21. Targeting $150M Revenue...
1
AGORACOM
Jun 06, 2021 07:05PM
VIDEO – Valeo Pharma Blood Thinner Approval Projected To Thicken Revenues By $30 MILLION Per Year (Not A Typo)
1
AGORACOM
Dec 22, 2020 06:01PM
AGORACOM Welcomes Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) With 7 Products To Be Launched In 2021 / 2022 ($45M. Estimated Peak Sales / Year)
1
AGORACOM
Dec 15, 2020 03:32PM
Digital Investor Awareness Program-VPH
1
kooter33
Dec 09, 2020 01:05PM
Log in to Agoracom
Sign in with Facebook
Sign in with Linkedin
Remember me
